Does federal law preempt state cannabis protection?
In specific contexts, yes. For DOT-regulated safety-sensitive employees under 49 CFR Part 40, the federal testing regime — including cannabis on the DOT 5-panel — applies regardless of state cannabis status. For federal contractors and grantees covered by the federal Drug-Free Workplace Act of 1988, the federal drug-free workplace requirements apply regardless of state cannabis protection. Outside these federally regulated populations, state employment law (including cannabis protection) controls.
The federal backbone — what it covers
Federal drug testing law in the United States consists of three principal authorities, each of which applies to a specific population:
1. 49 CFR Part 40 — DOT-regulated transportation workers
The Department of Transportation\'s "Procedures for Transportation Workplace Drug and Alcohol Testing Programs" (49 CFR Part 40) sets the testing procedures, panel, cutoffs, MRO process, and consequences for safety-sensitive transportation employees. The agency-specific operational rules layered on top of Part 40 are: FMCSA Part 382 (commercial motor vehicle operators); FAA Part 120 (pilots, flight crew, mechanics); FRA Part 219 (railroad operations); FTA Part 655 (transit); PHMSA Part 199 (pipelines); and USCG (vessel crew). The DOT 5-panel — currently THC, cocaine, opiates, amphetamines, and as of July 7, 2025, fentanyl/norfentanyl — applies uniformly.
2. Drug-Free Workplace Act of 1988 — federal contractors and grantees
The Drug-Free Workplace Act of 1988 (41 U.S.C. § 8101 et seq.) requires federal contractors and federal grantees to maintain a drug-free workplace policy, notify employees of prohibited substances and the consequences of violation, and report convictions for drug-related workplace offenses. The Act does not mandate testing, but it does require the policy framework, and most federal contractors implement testing as part of compliance. Cannabis remains a controlled substance under the federal Controlled Substances Act, so federal-contractor drug-free policies must continue to prohibit cannabis use even where the employee\'s state of residence has legalized cannabis.
3. SAMHSA Mandatory Guidelines — federal employee testing
The SAMHSA Mandatory Guidelines for Federal Workplace Drug Testing Programs govern testing of federal executive-branch employees and provide the underlying procedural standards that are incorporated into 49 CFR Part 40 for DOT-regulated employees. The Guidelines specify certified-lab requirements, chain-of-custody procedures, cutoff levels, and confirmation testing requirements. Most state drug-testing statutes either reference SAMHSA standards or require equivalent procedures.
Who is and isn't covered by the federal overlay
| Attribute | Covered by federal rules | Governed by state law only |
|---|---|---|
| Safety-sensitive transportation employees | DOT-regulated; 49 CFR Part 40 applies | N/A — they are federally regulated |
| Non-safety-sensitive employees of transportation companies | Not federally regulated for drug testing | State law governs |
| Federal contractors / grantees | Drug-Free Workplace Act of 1988 | N/A — Act applies |
| Subcontractors of federal contractors | Often covered, depends on contract | State law fills gaps |
| Federal executive-branch employees | SAMHSA Mandatory Guidelines | N/A |
| Private-sector employees of non-federal-contractor companies | Not federally regulated for testing | State law governs |
| State and local government employees | Not federally regulated unless DOT or federal-contractor | State law + Fourth Amendment govern |
Cannabis preemption — the practical rule
The most contested area of federal preemption in employment drug testing is cannabis. The practical rule across the country:
- DOT-regulated employees. Federal cannabis prohibition under the Controlled Substances Act applies via 49 CFR Part 40 regardless of state cannabis legalization. A positive cannabis test under the DOT 5-panel results in mandatory removal from safety-sensitive duty. State cannabis legalization or off-duty cannabis protection does not preempt the federal testing obligation.
- Federal contractors and grantees. The Drug-Free Workplace Act of 1988 requires maintenance of a drug-free workplace policy. Because cannabis is a Schedule I controlled substance under federal law, federal-contractor drug-free policies must continue to prohibit cannabis use. State cannabis legalization does not preempt the federal Act.
- Everyone else. For non-DOT, non-federal-contractor private-sector employees, state law controls. If the state has enacted cannabis off-duty protection or MMJ employee protection, that protection applies regardless of cannabis\'s federal status. The federal Controlled Substances Act does not preempt state employment-law cannabis protection.
State cannabis protection is generally not preempted
A common misconception is that state cannabis employee protections are preempted by federal law because cannabis remains illegal under the federal Controlled Substances Act. With few exceptions, this is incorrect. Federal preemption requires either an express preemption provision (which the CSA does not contain for employment-law purposes) or an "actual conflict" preventing dual compliance (which courts have generally not found for state cannabis employee protection).
The leading court decision on this point is Noffsinger v. SSC Niantic Operating Co. (D. Conn. 2018), in which the federal district court held that the Connecticut Palliative Use of Marijuana Act\'s anti-discrimination provision was not preempted by the federal CSA. Subsequent decisions in Arizona, Connecticut, Delaware, New Jersey, Pennsylvania, and Rhode Island have generally reached similar conclusions: state cannabis employee protection is not preempted by federal law outside the federal-contractor and DOT contexts.
Federal Drug-Free Workplace Act of 1988 — practical detail
The federal Drug-Free Workplace Act of 1988 applies to:
- Federal contractors with contracts of $100,000 or more (after subsequent statutory updates from the original $25,000 threshold)
- Federal grantees that receive federal grants of any amount
- The employees of these contractors and grantees who work on the federally funded contract or grant
Compliance requires:
- Written policy notifying employees that the unlawful manufacture, distribution, dispensation, possession, or use of a controlled substance is prohibited in the workplace.
- Drug-free awareness program informing employees about the dangers of drug abuse, the policy, available counseling, and the consequences of violations.
- Employee notification requirement: employees must notify the employer within five calendar days of any criminal drug conviction for a workplace violation.
- Employer notification requirement: the employer must notify the relevant federal contracting officer within 10 days of receiving notice of a conviction.
- Sanction or rehabilitation for employees convicted of workplace drug offenses, within 30 days of notice.
Notably, the Drug-Free Workplace Act of 1988 does not mandate testing — the Act is policy- and notification-based. Many federal contractors implement testing as part of compliance, but testing is not statutorily required by the Act itself. Testing requirements for federal contractors may arise from contract-specific provisions, agency-specific rules, or DOT-regulated safety-sensitive roles within the contractor\'s workforce.
DOT Drug & Alcohol Clearinghouse
The FMCSA Drug & Alcohol Clearinghouse, operational since January 6, 2020, is a database of drug and alcohol program violations for commercial driver\'s license (CDL) holders subject to FMCSA-regulated testing. Employers must query the Clearinghouse before hiring a CDL holder (pre-employment query) and annually for current CDL employees (annual query). Drivers with unresolved violations are "prohibited" from operating a CMV until they complete the Return-to-Duty process. The Clearinghouse is one of the most significant operational developments in federal drug testing law in the past decade.
The ADA overlay on federal testing
The federal Americans with Disabilities Act applies to drug testing in three ways:
- Pre-offer testing restrictions. Drug testing of applicants for illegal drug use is permissible, but testing for alcohol or for prescription medications (which may indicate a disability) is a "medical examination" under the ADA and is restricted to post-conditional-offer timing.
- Current illegal drug use exclusion. The ADA does not protect "current illegal drug use." Cannabis remains illegal under federal law, so the ADA generally does not require accommodation for medical cannabis use specifically.
- Underlying-condition accommodation. The ADA may require accommodation for the underlying medical condition for which an employee uses medical cannabis. This is a common pitfall — terminating an employee for a positive cannabis test without considering the ADA implications of the underlying condition can result in liability.
Federal-state compliance question?
Tell us about your situation — we'll point you to the right primary sources and (optionally) connect you with qualified employment counsel.
Sources & references
drugtest.co content is sourced from primary regulatory and clinical references. We do not cite gray-market or "how to pass" sources.
- Mandatory Guidelines for Federal Workplace Drug Testing Programs (Urine)
- Mandatory Guidelines for Federal Workplace Drug Testing Programs (Oral Fluid)
- Final Notice — Addition of Fentanyl and Norfentanyl to Federal Workplace Drug Testing Panels
- 49 CFR Part 40 — Procedures for Transportation Workplace Drug and Alcohol Testing Programs
- Procedures for Transportation Workplace Drug Testing Programs: Addition of Oral Fluid Specimen Testing
- DOT Agency Drug & Alcohol Testing Regulations
- FMCSA Drug & Alcohol Clearinghouse
- Drug-Free Workplace Act of 1988 (Federal Contractors)
- ADA: Drug Testing & Reasonable Accommodation Guidance